ASPM (Abnormal Spindle Microtubule Assembly) is a centrosomal protein implicated in mitotic spindle regulation and cell cycle progression. ASPM antibodies are immunological tools designed to detect and quantify ASPM expression in research settings. These antibodies are critical for studying ASPM's role in cancer biology, neurodevelopment, and immune regulation .
ASPM antibodies are validated for diverse experimental applications:
Prognostic Value: High ASPM expression correlates with poor prognosis in kidney renal clear cell carcinoma (KIRC), liver hepatocellular carcinoma (LIHC), and bladder cancer .
Immune Infiltration: ASPM overexpression is linked to increased infiltration of B cells, CD8+ T cells, and M2 macrophages in KIRC and LIHC tumors .
Isoform-Specific Roles:
Antibody Specificity:
Limitations: Inconsistent IHC results due to antibody cross-reactivity or tumor heterogeneity .
Therapeutic Targeting: ASPM promotes stemness in prostate cancer via Wnt/β-catenin signaling, suggesting potential for pathway inhibitors .
Immune Modulation: High ASPM levels correlate with M2 macrophage infiltration, indicating a role in immunosuppressive microenvironments .